Accumulation of PrPSc , an insoluble and protease-resistant pathogenic isoform of the cellular prion protein (PrP C ) is a hallmark in prion diseases. Branched polyamines, including PPI (poly(propylene imine)) dendrimers are able to remove protease resistant PrP Sc and abolish infectivity, offering possible applications for therapy. These dendrimer types are thought to act through their positively charged amino surface groups. In the present study the molecular basis of the anti-prion activity of dendrimers was further investigated employing modified PPI dendrimers, in which the positively charged amino surface groups were substituted with neutral carbohydrate units of maltose (mPPI) or maltotriose (m3PPI). Modification of surface groups greatly reduced the toxicity associated with unmodified PPI, but did not abolish its anti-prion activity, suggesting that the presence of cationic surface groups is not essential for dendrimer action. PPI and mPPI dendrimer of generation 5 were equally effective in reducing levels of protease-resistant PrP Sc (PrP res ) in a dose-and time-dependent manner in ScN2a cells, and in preexisting aggregates in homogenates from infected brain. Solubility assays revealed that total levels of PrP Sc in scrapie infected mouse neuroblastoma (ScN2a) cells were reduced by mPPI. Coupled with the known ability of polyamino dendrimers to render protease-resistant PrP Sc in pre-existing aggregates of PrP Sc susceptible to proteolysis, these findings strongly suggest that within infected cells dendrimers reduce total amounts of PrP Sc by mediating its denaturation and subsequent elimination.